Nuwellis (NUWE) Consolidated Net Income (2011 - 2026)
Nuwellis' (NUWE) quarterly Consolidated Net Income came in at -$4.5 million in Q1 2026, down 50.66% YoY from -$9.2 million in Q1 2025, and down 87.49% on a QoQ basis from -$2.4 million in Q4 2025.
Nuwellis (NUWE) Consolidated Net Income (2011 - 2026) Analysis & Trends
Nuwellis (NUWE) has 16 years of Consolidated Net Income data on file, last reported at -$4.5 million in Q1 2026.
- Quarterly Consolidated Net Income fell 50.66% year-over-year to -$4.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$19.0 million (down 93.4% YoY) and the FY2025 annual result came in at -$17.5 million, down 56.93% from the prior year.
- Consolidated Net Income eased to -$4.5 million in Q1 2026, from -$2.4 million in the prior quarter.
- In the past five years, Consolidated Net Income ranged from a high of $2.4 million in Q3 2024 to a low of -$12.6 million in Q2 2025.
- A 5-year average of -$4.0 million and a median of -$4.3 million in 2022 frame the typical range for Consolidated Net Income.
- Annual changes were most pronounced in 2023 — Consolidated Net Income sank 353.2% — and 2024, when it surged 169.97%.
- Tracing NUWE's Consolidated Net Income over 5 years: stood at -$1.4 million in 2022, then tumbled by 353.2% to -$6.2 million in 2023, then soared by 76.43% to -$1.5 million in 2024, then sank by 64.99% to -$2.4 million in 2025, then slumped by 87.49% to -$4.5 million in 2026.
- The last three Consolidated Net Income figures came in at -$4.5 million (Q1 2026), -$2.4 million (Q4 2025), and $468000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Nuwellis | 203,898.38 | -3.72 Mn | 1.50 Mn | -4.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.83 Mn |
| Mar 31, 2026 | -4.54 Mn |
| Dec 31, 2025 | -2.42 Mn |
| Sep 30, 2025 | 468,000.00 |
| Jun 30, 2025 | -12.55 Mn |
| Mar 31, 2025 | -3.01 Mn |
| Dec 31, 2024 | -1.47 Mn |
| Sep 30, 2024 | 2.36 Mn |
| Jun 30, 2024 | -7.73 Mn |
| Mar 31, 2024 | -4.33 Mn |
| Dec 31, 2023 | -6.23 Mn |
| Sep 30, 2023 | -3.37 Mn |
| Jun 30, 2023 | -4.85 Mn |
| Mar 31, 2023 | -6.49 Mn |
| Dec 31, 2022 | -1.37 Mn |
| Sep 30, 2022 | -3.87 Mn |
| Jun 30, 2022 | -4.29 Mn |
| Mar 31, 2022 | -4.47 Mn |
| Dec 31, 2021 | 15.82 Mn |
| Sep 30, 2021 | -5.27 Mn |